bevacizumab
roche
['#gi', 'cairo 5']
#asco22 #asco2022 #gioncology cairo 5 in either r-sided or ras/brafm all had potentially resectable dz folfox/bev versus folfoxiri/bev decisions re resectability made by robust panel both arms had initial aggressive chemo, then maintenance
Stanford Oncologist || BYU alum || Penn Med alum || author || American Studies amateur || religious studies amateur || podcasting @ https://t.co/KnVbI8oZ43